Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of Recombinant Human Thrombopoietin in Children With Malignant Solid Tumors and Lymphoma Receiving Ifosfamide, Carboplatin and Etoposide

NCT00187109 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.

NCT NCT00187109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00187109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of Recombinant Human Thrombopoietin in Children With Malignant Solid Tumors and Lymphoma Receiving Ifosfamide, Carboplatin and Etoposide
Lead sponsor
St. Jude Children's Research Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2000
Completion date
February 28, 2007
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

germ cell tumors, hepatic cancer, neuroblastoma, osteosarcoma, rhabdomyosarcoma